Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Summit Hotel Properties Inc.

WKN: A1H7RF / Name: Summit Htl Prti / Stock / Residential & Commercial REIT / Small Cap /

?
0.840%

Summit Materials Inc.

WKN: A14QAG / Symbol: SUM / Name: Summit Materials / Stock / Construction Materials / Mid Cap /

€50.50
1.000%

Sun Summit Minerals Corp.

WKN: A402FR / Name: Sun Summit Minerals Corp. / Stock / ? /

?
0.000%

Summit Midstream Corp.

WKN: A40J3V / Name: Summit Midstream Corp. / Stock / ? /

?
-0.190%

Summit to Divest Late-Stage Antibiotic Drug to Biossil in $105M Deal
Summit to Divest Late-Stage Antibiotic Drug to Biossil in $105M Deal

Summit Therapeutics SMMT has entered into an agreement with Toronto-based Biossil Inc. to divest its investigational antibiotic candidate, ridinilazole. The late-stage asset was being developed for

Summit Therapeutics Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Coal mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/25526de2-54da-40ae-ba56-1e25dead3e81.png
Summit Therapeutics Q2 Earnings Call Highlights

Key Points

Is Summit Hotel Properties (INN) a Great Value Stock Right Now?Photo, wide shot, wide-angle lens,  Clothing manufacturer, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/4c710447-f68a-47bc-a682-c2d83e801596.png
Is Summit Hotel Properties (INN) a Great Value Stock Right Now?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

SMMT Shares Updated Ivonescimab Survival Data From NSCLC Study
SMMT Shares Updated Ivonescimab Survival Data From NSCLC Study

Summit Therapeutics SMMT announced updated overall survival ("OS") data from the phase III HARMONi study evaluating its investigational antibody ivonescimab in certain patients with non-small cell

SMMT's Q2 Loss Wider Than Expected, Ivonescimab Development in Focus
SMMT's Q2 Loss Wider Than Expected, Ivonescimab Development in Focus

Summit Therapeutics SMMT reported a second-quarter 2026 loss per share of 28 cents, wider than the Zacks Consensus Estimate of a loss of 26 cents per share. In the year-ago period, the company had

Nvidia Aktie: 1,5 Milliarden Dollar für Amkor-PackagingPhoto, wide shot, wide-angle lens,  Software company, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/da273d82-9e59-413a-99b3-2b0094ff0854.png
Nvidia Aktie: 1,5 Milliarden Dollar für Amkor-Packaging

Auf dem AI Summit in San Francisco haben südkoreanische Industriekonzerne und US-Technologiefirmen in den…

Der Beitrag Nvidia Aktie: 1,5 Milliarden Dollar für Amkor-Packaging erschien zuerst auf kap